Daan Gene Co., Ltd. (SHE:002030)
China · Delayed Price · Currency is CNY 6.71
-0.37 (-5.23%)
Jun 1, 2026, 3:04 PM CST
Daan Gene Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -895.46 | -744.38 | -925.17 | 104.66 | 5,412 | 3,618 |
Depreciation & Amortization | 295.33 | 295.33 | 350.36 | 357.14 | 298.44 | 192.02 |
Other Amortization | 24.53 | 24.53 | 11.37 | 10.82 | 34.78 | 20.45 |
Loss (Gain) From Sale of Assets | -5.48 | -5.48 | -9.1 | 3.04 | 1.15 | -0.11 |
Asset Writedown & Restructuring Costs | 385.84 | 385.84 | 31.28 | 80.89 | 329.79 | 15 |
Loss (Gain) From Sale of Investments | -54 | -54 | 429.58 | -409.44 | -345.15 | -135.35 |
Provision & Write-off of Bad Debts | 105.04 | 105.04 | 397.98 | 142.36 | 297.82 | 130.73 |
Other Operating Activities | 170.57 | 28.43 | 42.35 | 169.99 | 333.6 | 28.07 |
Change in Accounts Receivable | 398.87 | 398.87 | 745.69 | 1,768 | -2,659 | -953.23 |
Change in Inventory | 41.27 | 41.27 | 80.69 | -61.27 | -112.02 | -187.42 |
Change in Accounts Payable | -178.57 | -178.57 | -715.42 | -1,389 | 649.84 | 645.12 |
Operating Cash Flow | 310.55 | 319.49 | 300.33 | 780.11 | 4,155 | 3,305 |
Operating Cash Flow Growth | -12.13% | 6.38% | -61.50% | -81.22% | 25.73% | 31.42% |
Capital Expenditures | -215.06 | -239 | -174.41 | -572.77 | -1,503 | -658.75 |
Sale of Property, Plant & Equipment | 0.41 | 0.42 | 0.11 | 0.45 | 0.01 | 0.15 |
Cash Acquisitions | - | - | - | - | - | -0.04 |
Divestitures | - | - | 0 | - | - | 0.02 |
Investment in Securities | -448.76 | -428.42 | -71.95 | 442.98 | -505.95 | -746.99 |
Other Investing Activities | 19.64 | 29.68 | 28.86 | 65.65 | 48.77 | 26.33 |
Investing Cash Flow | -643.77 | -637.32 | -217.39 | -63.69 | -1,960 | -1,379 |
Short-Term Debt Issued | - | 123.01 | 147.85 | 318.52 | 124.6 | 284.55 |
Long-Term Debt Issued | - | 4.9 | 46.8 | 35 | 50.03 | 45 |
Total Debt Issued | 149.1 | 127.91 | 194.65 | 353.52 | 174.64 | 329.55 |
Short-Term Debt Repaid | - | -158.05 | -357.67 | -125.46 | -284.34 | -398.75 |
Long-Term Debt Repaid | - | -5.96 | -15.06 | -82.7 | -104.33 | -52.08 |
Total Debt Repaid | -142.38 | -164.01 | -372.73 | -208.16 | -388.67 | -450.83 |
Net Debt Issued (Repaid) | 6.72 | -36.1 | -178.08 | 145.36 | -214.03 | -121.28 |
Common Dividends Paid | -8.62 | -8.46 | -27.88 | -2,469 | -1,570 | -496.31 |
Other Financing Activities | 0.95 | - | - | - | -10.96 | -8.96 |
Financing Cash Flow | -0.94 | -44.55 | -205.96 | -2,323 | -1,795 | -626.55 |
Foreign Exchange Rate Adjustments | -1.95 | -1.33 | 1.11 | 2.26 | 27.53 | -3.24 |
Net Cash Flow | -336.11 | -363.71 | -121.9 | -1,605 | 427.93 | 1,295 |
Free Cash Flow | 95.49 | 80.49 | 125.92 | 207.34 | 2,652 | 2,646 |
Free Cash Flow Growth | -56.24% | -36.08% | -39.27% | -92.18% | 0.24% | 23.08% |
Free Cash Flow Margin | 12.94% | 10.62% | 14.76% | 17.56% | 22.02% | 34.52% |
Free Cash Flow Per Share | 0.07 | 0.06 | 0.09 | 0.14 | 1.89 | 1.89 |
Cash Income Tax Paid | 27.66 | 29.16 | 50.76 | 253.76 | 1,504 | 754.19 |
Levered Free Cash Flow | 312.56 | 129.51 | 425.76 | 432.93 | 1,457 | 1,665 |
Unlevered Free Cash Flow | 315.09 | 132.13 | 431.85 | 439.21 | 1,466 | 1,671 |
Change in Working Capital | 278.24 | 278.24 | -37.15 | 320.01 | -2,206 | -555.75 |